Protein Summary
Thermolysin-like specificity, but is almost confined on acting on polypeptides of up to 30 amino acids (PubMed:15283675, PubMed:8168535). Biologically important in the destruction of opioid peptides such as Met- and Leu-enkephalins by cleavage of a Gly-Phe bond (PubMed:17101991). Able to cleave angiotensin-1, angiotensin-2 and angiotensin 1-9 (PubMed:15283675). Involved in the degradation of atrial natriuretic factor (ANF) (PubMed:2531377, PubMed:2972276). Displays UV-inducible elastase activity toward skin preelastic and elastic fibers (PubMed:20876573). The protein encoded by this gene is a type II transmembrane glycoprotein and a common acute lymphocytic leukemia antigen that is an important cell surface marker in the diagnosis of human acute lymphocytic leukemia (ALL). The encoded protein is present on leukemic cells of pre-B phenotype, which represent 85% of cases of ALL. This protein is not restricted to leukemic cells, however, and is found on a variety of normal tissues. The pr ...more
- ENST00000360490
- ENSP00000353679
- ENSG00000196549
- ENST00000460393
- ENSP00000418525
- ENST00000462745
- ENSP00000419653
- ENST00000492661
- ENSP00000420389
- ENST00000493237
- ENSP00000417079
- ENST00000615825
- ENSP00000478173
- EPN
- NEP
- SFE
- CD10
- CALLA
- CMT2T
- SCA43
Most Knowledge About | Knowledge Value
(0 to 1 scale) | ||
---|---|---|---|
PubMedID | 0.95 | ||
cellular component | 0.8 | ||
disease | 0.78 | ||
protein domain | 0.73 | ||
hub protein | 0.71 | ||
Protein Classes
IDG Development Level Summary
These are targets about which virtually nothing is known. They do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 6023.3 (req: < 5)
Gene RIFs: 290 (req: <= 3)
Antibodies: 2082 (req: <= 50)
These targets do not have known drug or small molecule activities
- AND - satisfy two or more of the following criteria:
Pubmed score: 6023.3 (req: >= 5)
Gene RIFs: 290 (req: > 3)
Antibodies: 2082 (req: > 50)
- OR - satisfy the following criterion:
Gene Ontology Terms: 19
Target has at least one ChEMBL compound with an activity cutoff of < 30 nM - AND - satisfies the preceding conditions
Active Ligands: 394
Target has at least one approved drug - AND - satisfies the preceding conditions
Active Drugs: 2